The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
A fast-growing, cloud-native SaaS company headquartered in Bangalore with offices in the US, UK, and Europe, specializing in pharmacovigilance (PV) and clinical trial IT solutions for the global life sciences industry. The company offers an all-in-one platform combining intake, case processing, regulatory submissions, and signal detection — reducing IT costs by up to 70% and time-to-compliance by 30%.
Founded in 2017, the company has a domain-specialized team of 65+ employees based in India and supports 100+ direct clients and over 160 end clients across more than 15 countries.
Core Platform Capabilities
Unified PV database with AS2 Gateway
Web, email, and MICC intake modules
Case processing, auto-narratives, signal detection
E2B R2/R3 support and real-time analytics
Integrated CTMS, EDC, eTMF, ePRO, IWRS, and eConsent modules
Differentiation
AI-powered automations for case booking, triage, and processing
End-to-end unified system (vs. fragmented tools in legacy stacks)
A fast-growing, cloud-native SaaS company headquartered in Bangalore with offices in the US, UK, and Europe, specializing in pharmacovigilance (PV) and clinical trial IT solutions for the global life sciences industry. The company offers an all-in-one platform combining intake, case processing, regulatory submissions, and signal detection — reducing IT costs by up to 70% and time-to-compliance by 30%.
Founded in 2017, the company has a domain-specialized team of 65+ employees based in India and supports 100+ direct clients and over 160 end clients across more than 15 countries.
Core Platform Capabilities
Unified PV database with AS2 Gateway
Web, email, and MICC intake modules
Case processing, auto-narratives, signal detection
E2B R2/R3 support and real-time analytics
Integrated CTMS, EDC, eTMF, ePRO, IWRS, and eConsent modules
Differentiation
AI-powered automations for case booking, triage, and processing
End-to-end unified system (vs. fragmented tools in legacy stacks)
Description
A fast-growing, cloud-native SaaS company headquartered in Bangalore with offices in the US, UK, and Europe, specializing in pharmacovigilance (PV) and clinical trial IT solutions for the global life sciences industry. The company offers an all-in-one platform combining intake, case processing, regulatory submissions, and signal detection — reducing IT costs by up to 70% and time-to-compliance by 30%.
Founded in 2017, the company has a domain-specialized team of 65+ employees based in India and supports 100+ direct clients and over 160 end clients across more than 15 countries.
Core Platform Capabilities
Unified PV database with AS2 Gateway
Web, email, and MICC intake modules
Case processing, auto-narratives, signal detection
E2B R2/R3 support and real-time analytics
Integrated CTMS, EDC, eTMF, ePRO, IWRS, and eConsent modules
Differentiation
AI-powered automations for case booking, triage, and processing
End-to-end unified system (vs. fragmented tools in legacy stacks)
Inbuilt regulatory compliance tools (e.g., submissions, reporting)
Trusted by top 3 of India’s top 10 pharma companies
Strategic Footprint
Strong presence in India, USA, UK, and broader Europe
Embedded in global CROs and expanding via partnerships (e.g., Wipro, Persistent, Cognizant)
Actively used across 250+ clinical studies
Vision
2025: AI-led automation of pharmacovigilance workflows
2030: Become a global top-10 PV IT provider capturing 30% market share
Basic Details
Target Price:
$ 0
Gross Revenue
$3,000,000
EBITDA
$1,000,000
Business ID:
L#20250961
Country
India
Detail
Similar Businesses
Published on July 9, 2025 at 7:01 am. Updated on July 9, 2025 at 7:05 am
SAAS Software Solutions & AI/ML
$90,000,000
Software & SAAS
Fully Remote Career Coaching Firm
$7,000,000
Software & SAAS
CPaaS Business providing APIs for SMS, Email, Voice, Authentication
$25,000,000
Software & SAAS
Fast Growing SaaS and Food Delivery Service
$1,700,000
Software & SAAS
Leading Online SAAS Selling Power Points PPTX Presentations and Slides
$28,000,000
Software & SAAS
International IT SaaS company to process business communications
$28,812,579
Software & SAAS
PREVIOUS PROPERTY
Premium Italian Luxury Yacht Manufacturing Business
NEXT PROPERTY
Historical Leading Digital Commerce Magento & Shopify Extension Provider